Management Team

Focusing our experience and insight on your goals

The b-next executive team brings you the benefit of senior, results-oriented professionals who have spent their careers at the forefront of compliance and risk management issues. We offer unique expertise, global perspective and our personalized commitment to minimize your risk and help you realize positive returns under all market conditions.

• Wolfgang Fabisch

  Co-Founder & Chief Executive Officer

  +

  Wolfgang Fabisch, as co-founder and CEO of b-next Group, has overall strategic and operational responsibility for its businesses. With over 25 years of professional and management experience in governance, risk and compliance (GRC) for the financial sector, he is a respected industry executive who regularly lectures on these topics. Before founding b-next in 1989, Mr. Fabisch held senior positions at IBM and Reuters. He holds a university degree in business administration.

• Stefan Queck

  Business Development Manager

  +

  Stefan Queck is responsible for Business Development at b-next, where he leads product and customer initiatives. Upon joining
  b-next Group in 2006, he brought a long and distinguished professional career at two prestigious German banking institutions. Since joining b-next he has played a key role in next-generation product development as well as the company's international expansion. Mr. Queck is a graduate in business management with an emphasis in banking.

• Andreas Müller

  Operational Manager

  +

  Andreas Müller joined the b-next management team in June 2011 with responsibility for operational performance, ensuring that resources are optimally aligned to customer and market needs. Following completion of his studies in business administration, Mr. Müller held a progression of professional and senior management positions in treasury, controlling, consulting and internal audit at a number of prominent companies, including DaimlerChrysler Aerospace AG and Reemtsma GmbH. He was most recently head of finance and controlling for a pharmaceutical company.